CHAPEL HILL, N.C., June 22, 2018 /PRNewswire/ -- Pharmaceutical companies are increasingly using digital engagement channels to more effectively communicate with their customers.
Unlike many other operational areas of pharma, the performance of digital marketing can be measured to evaluate the impact and effectiveness of each digital channel. According to a new study by Best Practices, LLC, various reach and conversion metrics were frequently rated to be the most effective measures to assess performance in many digital channels. While overall volume metrics are best suited to measuring SEO performance, many companies prefer actual conversion metrics for bottom-of-the-funnel channels such as branded and non-branded websites and mobile apps. Middle-of-the-funnel activities such as email marketing campaigns are often measured by simple reach metrics, the study found.
"Forge Top-Tier Biopharma Digital Strategy & Experience" is a new report that examines how leading pharma and medical device firms use evolving tools and tactics to educate key customers, enhance reach, raise sales force effectiveness, measure and increase customer satisfaction, and offset declining HCP access. For this research, Best Practices, LLC engaged 21 digital marketing leaders at 19 companies through a benchmarking survey instrument. Nearly 70% of participants serve at the level of director or above.
Download a complimentary report summary at: http://www.best-in-class.com/rr1500.htm. This 72-page study will serve as a resource for driving digital marketing performance in the healthcare industry.
This study is the result of research produced by Best Practices' Digital Technology Consortium, a service that brings together executives from various leading companies around the world to tackle one question:
How do we manage and implement digital technology as an asset not a utility?
Consortium participants will receive results of customized digital technology benchmark studies conducted among members throughout the service year; members will also participate in roundtable peer knowledge exchanges to share best practices in digital technology. Additionally, members will have access to analysis, intelligence and the Best Practices Database for Technology Leaders.
Please contact us with any questions regarding this study or click this link to find out more about the Digital Technology Consortium.
ABOUT BEST PRACTICES, LLCBest Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.
Advertisement
Unlike many other operational areas of pharma, the performance of digital marketing can be measured to evaluate the impact and effectiveness of each digital channel. According to a new study by Best Practices, LLC, various reach and conversion metrics were frequently rated to be the most effective measures to assess performance in many digital channels. While overall volume metrics are best suited to measuring SEO performance, many companies prefer actual conversion metrics for bottom-of-the-funnel channels such as branded and non-branded websites and mobile apps. Middle-of-the-funnel activities such as email marketing campaigns are often measured by simple reach metrics, the study found.
Advertisement
"Forge Top-Tier Biopharma Digital Strategy & Experience" is a new report that examines how leading pharma and medical device firms use evolving tools and tactics to educate key customers, enhance reach, raise sales force effectiveness, measure and increase customer satisfaction, and offset declining HCP access. For this research, Best Practices, LLC engaged 21 digital marketing leaders at 19 companies through a benchmarking survey instrument. Nearly 70% of participants serve at the level of director or above.
Download a complimentary report summary at: http://www.best-in-class.com/rr1500.htm. This 72-page study will serve as a resource for driving digital marketing performance in the healthcare industry.
This study is the result of research produced by Best Practices' Digital Technology Consortium, a service that brings together executives from various leading companies around the world to tackle one question:
How do we manage and implement digital technology as an asset not a utility?
Consortium participants will receive results of customized digital technology benchmark studies conducted among members throughout the service year; members will also participate in roundtable peer knowledge exchanges to share best practices in digital technology. Additionally, members will have access to analysis, intelligence and the Best Practices Database for Technology Leaders.
Please contact us with any questions regarding this study or click this link to find out more about the Digital Technology Consortium.
ABOUT BEST PRACTICES, LLCBest Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.
View original content:http://www.prnewswire.com/news-releases/digital-technology-consortium-report-provides-window-into-future-trends-for-digital-marketing-budget-staffing-and-performance-measurement-300670956.html
SOURCE Best Practices, LLC
